48.5 D+
Ipamorelin
Also known as: NNC 26-0161
Emerging Research Category 2 Restricted
Research Evidence 32.0/100
Safety Profile 65.0/100
2 Clinical Trials
PHASE2: 2
- Safety and Efficacy of Ipamorelin Compared to Placebo for the Recovery of Gastrointestinal Function PHASE2 COMPLETED Helsinn Therapeutics (U.S.), Inc
- Safety and Efficacy of Ipamorelin for Management of Post-Operative Ileus PHASE2 COMPLETED Helsinn Therapeutics (U.S.), Inc
17 Research Papers
- Doping control analysis of seven bioactive peptides in horse plasma by liquid chromatography-mass spectrometry. Anal Bioanal Chem unknown
- The growth hormone secretagogue receptor 1a agonists, anamorelin and ipamorelin, inhibit cisplatin-induced weight loss in ferrets: Anamorelin also exhibits anti-emetic effects via a central mechanism. Physiol Behav unknown
- The influence of ghrelin agonist ipamorelin acetate on the hypothalamic-pituitary-testicular axis in a cichlid fish, Oreochromis mossambicus. Anim Reprod Sci unknown
- A high-throughput LC-MS/MS screen for GHRP in equine and human urine, featuring peptide derivatization for improved chromatography. Drug Test Anal unknown
- Simplifying and expanding the screening for peptides <2 kDa by direct urine injection, liquid chromatography, and ion mobility mass spectrometry. J Sep Sci unknown
Showing 5 of 17 papers by citation count.
FDA Data
Not FDA-Approved
Ipamorelin has not been evaluated by the FDA for safety or efficacy. It is not approved for human therapeutic use in the United States.
This peptide is classified as FDA Category 2 — it is prohibited from use in compounding pharmacies effective 2024. Obtaining it requires unregulated sources.
Frequently Asked Questions
Is Ipamorelin FDA approved?
No, Ipamorelin is not FDA approved. It is classified as FDA Category 2 and is banned from compounding pharmacies.
How many clinical trials has Ipamorelin been studied in?
Ipamorelin has been studied in 2 registered clinical trials. CheckPeptides tracks phase, status, and sponsor data for each trial.
What is the trust score for Ipamorelin?
Ipamorelin has a CheckPeptides trust score of 48.5/100 (grade: D+). This score is based on clinical trial volume, research paper quality, FDA data, and evidence classification.
Last verified: April 7, 2026
Quick Facts
- Classification
- Ghrelin mimetic / GHS
- Molecular Weight
- 711.9 Da
- PubChem
- CID 9831659 ↗
- Regulatory Status
- N/A
Score Breakdown
Research Evidence 32.0/100
Safety Profile 65.0/100
Evidence Summary
- Clinical Trials
- 2
- Research Papers
- 17
- Trust Score
- 48.5/100
- Grade
- D+